Infusion Therapy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030. The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy devices market throughout the forecast period spanning from 2024 to 2030.

Infusion Therapy Devices Market Dynamics:

The global prevalence of diabetes and cancer is driving significant growth in the market for infusion therapy devices. According to the International Diabetes Federation (IDF), in 2021, an estimated 537 million adults aged 20-79 were living with diabetes. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, 541 million individuals were reported to have Impaired Glucose Tolerance (IGT), putting them at high risk of developing Type 2 diabetes. Notably, three-quarters of adults with diabetes reside in low- and middle-income countries, where the need for advanced medical devices like insulin pumps is crucial. These devices are essential for continuous and precise insulin delivery, and vital for effective blood sugar management.

The demand for infusion therapy devices is also bolstered by the cancer statistics published by the American Cancer Society. In 2020, there were an estimated 19.3 million new cancer cases worldwide, excluding 18.1 million cases of non-melanoma skin cancer. Breast cancer has emerged as the most commonly diagnosed cancer, comprising 11.7% of new cases, surpassing lung cancer, which accounts for 11.4% of cases. The other prevalent cancers include colorectal (10.0%), prostate (7.3%), and stomach (5.6%). Infusion therapy is integral to chemotherapy delivery, further underscoring the critical role of these devices in cancer treatment.

The infusion therapy devices market is also benefiting from increased collaborations and partnerships among industry players. For instance, in August 2023, Monidor Oy, a Finnish health technology company, partnered with B. Braun, a leading international medical device manufacturer, to enhance remote IV therapy monitoring. Such partnerships are pivotal in advancing the field of infusion therapy.

In another significant development, Eitan Medical introduced a groundbreaking connected multi-therapy ambulatory infusion system, Avoset, in April 2021. Avoset is designed to transform post-acute care and specialized infusion therapy with its compact design and remote monitoring capabilities, enhancing patient safety and user experience.

Despite these positive trends, the market faces challenges such as the high cost of infusion therapy devices and the risk of infection associated with their use. These factors may restrain market growth during the forecast period of 2024 to 2030. However, the overall expansion of the infusion therapy device market is expected to continue, propelled by the rising need to manage chronic diseases like diabetes and cancer effectively.

Infusion Therapy Devices Market Segment Analysis:

Infusion Therapy Devices Market by Product Type (Syringe Pumps, Large Volume Pumps (LVP), Elastomeric Pumps, and Others), Mobility (Portable Infusion Pumps, and Stationary Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The syringe infusion pump segment is poised to capture a substantial revenue share of the infusion therapy devices market in 2023. Known for their precision, syringe infusion pumps, or syringe drivers, are crucial for administering small volumes of fluids, such as medications or nutrients, directly into a patient’s bloodstream.

Syringe infusion pumps offer several advantages, making them indispensable in clinical settings. These devices are versatile, designed for both portable and stationary use, and incorporate an internal heater for temperature control. This feature is particularly beneficial for administering fluids that require specific temperature settings to maintain efficacy. Furthermore, syringe pumps can interface with computers, allowing healthcare providers to program the device for enhanced accuracy and to track the history of infusions, minimizing the potential for errors.

The capability to deliver fluids with higher viscosity is another notable benefit. These pumps can operate continuously for up to 24 hours, ensuring that patients receive a consistent and precise dosage of medication over a specified period. They also allow for the mixing and administering of multiple medications simultaneously, significantly reducing the need for frequent injections and improving patient comfort.

The demand for syringe infusion pumps is expected to grow due to their ability to deliver an accurate dosage over extended periods, which is increasingly essential in both acute and chronic care settings. This growth is further supported by the introduction of new and innovative products that have received regulatory approvals. For example, in August 2021, Baxter’s Novum IQ syringe infusion pump received FDA 510(k) clearance. This device enhances the infusion process with advanced safety features, improved connectivity, configurable anesthesia care settings, and a user-friendly interface, emphasizing precision and reliability in medication delivery.

Given these developments, the syringe infusion pump segment is anticipated to experience notable growth, significantly contributing to the expansion of the overall infusion therapy device market from 2024 to 2030.

North America Is Expected To Dominate The Overall Infusion Therapy Devices Market:

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

According to 2023 data from the Centers for Disease Control and Prevention (CDC), approximately 53.2 million people, or one in five U.S. adults, had doctor-diagnosed arthritis between 2019 and 2021. Arthritis is more prevalent among women (20.9%) than men (16.3%), and the likelihood of developing the condition increases with age. Notably, the prevalence of arthritis is higher among those with no leisure-time physical activity (30.9%) compared to those who are somewhat active (27.0%) or meet physical activity recommendations (18.8%). For individuals with arthritis where oral medications are ineffective, infusion therapy serves as a vital alternative, offering direct and rapid delivery of medication into the bloodstream.

The market is also stimulated by the strategic activities of leading companies based in the region, such as Mindray, Baxter, and Becton, Dickinson and Company. These firms play a critical role in the sector's growth through continuous innovation and new product offerings. For instance, in February 2023, Mindray launched its BeneFusion i and u Series infusion systems, which are notable for their high precision and user-friendly design. Featuring an intuitive full touch screen and a flat design that highlights essential parameters, the BeneFusion series enhances visibility and usability for medical staff, allowing for safer and more precise operations.

The convergence of these factors, along with ongoing product launches and regulatory approvals, underscores the significant role North America will continue to play in driving the growth of the global Infusion Therapy Devices market from 2024 to 2030.

Infusion Therapy Devices Market Key Players:

Some of the key market players operating in the Infusion Therapy Devices Market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and Others.

Recent Developmental Activities In The Infusion Therapy Devices Market:

• In August 2021, Baxter got the approval of U.S. Food Drug Administration (FDA) 510 (k) clearance for its Novum IQ syringe infusion pump.
• In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical from Smiths Group plc. This strategic move brings together a comprehensive portfolio encompassing syringe infusion devices, ambulatory infusion devices, vascular access solutions, and vital care products. By integrating the ambulatory infusion devices and vascular access offerings from Smiths Group plc with ICU Medical's Vital care products, the newly formed entity emerges as a prominent player in the infusion therapy sector, poised to exert a significant global presence.

Key Takeaways From The Infusion Therapy Devices Market Report Study

• Market size analysis for current Infusion Therapy Devices market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Infusion Therapy Devices market.
• Various opportunities are available for the other competitors in the Infusion Therapy Devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current Infusion Therapy Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Infusion Therapy Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Infusion Therapy Device Market Report Study

• Infusion Therapy Devices product providers
• Research organizations and consulting companies
• Infusion Therapy Devices organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Infusion Therapy Devices
• Various end-users who want to know more about the infusion therapy device market and the latest innovations and developments in the infusion therapy device market.

Frequently Asked Questions For The Infusion Therapy Devices Market

1. What are Infusion Therapy Devices?

An infusion pump is a medical device utilized to administer fluids, including nutrients and medications, into a patient's body with precise control over the dosage. Widely employed across various clinical environments such as hospitals, nursing homes, and home care settings, these devices play a crucial role in medical treatment.

2. What is the market for global Infusion Therapy Devices?

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030.

3. What are the drivers for the global infusion therapy devices market?

The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy device market throughout the forecast period spanning from 2024 to 2030.

4. Who are the key players operating in the global infusion therapy devices market?

Some of the key market players operating in the Infusion Therapy Devices market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and others.

5. Which region has the highest share in the infusion therapy devices market?

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.


This product will be delivered within 2 business days.